We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
4d Pharma Plc | LSE:DDDD | London | Ordinary Share | GB00BJL5BR07 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 16.36 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
09/6/2021 16:30 | Keep them coming Max while your investment here goes down the toilet.No difference to me.Lol.. | bluebear1 | |
09/6/2021 16:29 | Aaaw didums can't take what you dish out | 5maxi | |
09/6/2021 16:24 | Shares go up and down Bear just that guy on top of your mum 9 months before you appeared | 5maxi | |
09/6/2021 16:20 | Vile shorters. Hope they get their comeuppance very soon. | on target | |
09/6/2021 16:19 | So many are waiting on the sidelines to pile in at the right price | hamidahamida | |
09/6/2021 16:17 | Head for a RED finish | hamidahamida | |
09/6/2021 16:17 | Sure they are..lol..lol..Engag | bluebear1 | |
09/6/2021 16:13 | Only been here for 9 months nearly all my buys are in 40-60p range. Great value for the patient and we all now this sector is turning in US and timed nicely with rich newsflow to come over next few months... | blueblood | |
09/6/2021 16:10 | Wiped out..Lol...Your looking in the mirror my friend.I know the truth hurts, not my fault you can't see your being played. | bluebear1 | |
09/6/2021 16:09 | F off you obnoxious tw*t. Just because you've been wiped out previously and don't hold isn't reason to slag company all the time. You got nothing better to do like signing on.... | blueblood | |
09/6/2021 16:06 | Timberrrrrrrr!!!! | bluebear1 | |
09/6/2021 16:06 | Ive picked up a stalker Its what happens when you challenge the boiler room crew. Scamming muppets | kaka47 | |
09/6/2021 16:03 | SP tanked from 10 pounds to 90p let us get into the minds of delusional DDDD rampers and see how they think...Tree shakeMMs want your sharesIts the MMs who are making negative posts to relieve the weak holdersGlad they dumped COVID treatment now we can channel all the funds towards our golden goose treatmentsLong and strongKeep hold of your Golden ticketsBuy the dipShort term pain for long term gainIt is only a temporary setbackI am glad we listed on Nasdaq yanks know how to value companiesIn Duncan we trustWe are gonna need a bigger boat | kaka47 | |
09/6/2021 15:54 | Lol, as I type the retreat begins. | bluebear1 | |
09/6/2021 15:53 | This will hit 81-83p region soon. | bluebear1 | |
09/6/2021 15:49 | Nice to see a rise here for a change. | 1airbag | |
09/6/2021 15:39 | Seller finally cleared? | cheaky monkey | |
09/6/2021 15:36 | They are targetting 120 in part B of the phase 2 MRx0518 + Keytruda clinical trial and had 24 enrolled on 3rd of February! I think that they will be targetting a fast track here. | devonlad | |
09/6/2021 15:30 | Interesting comments from PDSB re number of patients needed in Phase II before going to FDA for Pivotal Trial talks and expedited approval I think v.encouraging for 4D Seems like less than 100 may be enough | the stigologist | |
09/6/2021 15:29 | Well done ok of this mornings buy... back to 180p :) | g2theary | |
09/6/2021 15:22 | Bradders, ot, yes I know, I hold a small few there. The point was more to do with the fact that the safety profile of DDDD's drugs is outstanding, I don't think that the RENE issue is anything more than coincidental but it just goes to show how important the safety is to drug trials really, that was more my point, I think! | devonlad |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions